MBX — Microbix Biosystems Balance Sheet
0.000.00%
Last trade - 00:00
- CA$45.80m
- CA$39.64m
- CA$16.51m
- 73
- 52
- 59
- 64
2019 September 30th | 2020 September 30th | 2021 September 30th | 2022 September 30th | 2023 September 30th | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Short Term Investments | 0.096 | 0.093 | 9.99 | 13.5 | 11.6 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 1.78 | 1.89 | 4.21 | 3.09 | 4.18 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Current Assets | 6.45 | 6.49 | 19.1 | 22.4 | 22.3 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 6.65 | 7.36 | 8.08 | 8.91 | 8.93 |
Net Intangible Assets | |||||
Other Long Term Assets | |||||
Total Assets | 19.6 | 15.6 | 28.8 | 33.1 | 35.7 |
Payable / Accrued | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 4.77 | 4.09 | 5.19 | 2.65 | 4.35 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 9.09 | 8.98 | 10.3 | 8.21 | 11 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 10.5 | 6.62 | 18.6 | 24.9 | 24.6 |
Total Liabilities & Shareholders' Equity | 19.6 | 15.6 | 28.8 | 33.1 | 35.7 |
Total Common Shares Outstanding |